Results 251 to 260 of about 98,296 (378)
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje +3 more
wiley +1 more source
Bisphosphonate Use in Acute Spinal Cord Injury: A Focused Systematic Review on Zoledronic Acid. [PDF]
Mun S +5 more
europepmc +1 more source
Oral Bisphosphonates for Colorectal Cancer Prevention: A Meta-Analytic Reappraisal Beyond Bone Health. [PDF]
Giusto EA +4 more
europepmc +1 more source
Letters to the Editor: Bisphosphonates - clinical applications in osteoporosis [PDF]
Alasdair Livingston
openalex +1 more source
The contemporary management of prostate cancer
Abstract Prostate cancer is the most common cancer in two thirds of the world, with an expected doubling in both incidence and mortality in the next two decades. No strong environmental associations exist for the development of prostate cancer; therefore, lifestyle measures are unlikely to mitigate this increasing burden.
Deep Chakrabarti +11 more
wiley +1 more source
Targeted Gene Sequencing in a Male Adult Diagnosed With X-Linked Osteoporosis Due to a Novel p.(Arg398Profs*2) <i>PLS3</i> Variant. [PDF]
Ye S +4 more
europepmc +1 more source
Advanced perspectives on and clinical usefulness of bisphosphonates Introduction [PDF]
Terri G Davidson
openalex +1 more source
The Development and Challenges of PET/MRI Dual‐Modality Imaging Probes—An Update
ABSTRACT The integration of Positron emission tomography (PET) with Magnetic resonance imaging (MRI) combines the functional imaging capabilities of PET with the high‐resolution anatomical detail of MRI, creating a synergistic platform for advanced diagnostic imaging and image‐guided therapies. Central to the success of this dual‐modality system is the
Maryam Sabbaghan +5 more
wiley +1 more source

